AJP - Heart AJP: Heart and Circulatory Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 288: H2280-H2288, 2005. First published December 16, 2004; doi:10.1152/ajpheart.00851.2004
0363-6135/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/5/H2280    most recent
00851.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gardiner, S. M.
Right arrow Articles by Bennett, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gardiner, S. M.
Right arrow Articles by Bennett, T.

Involvement of CB1-receptors and {beta}-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats

S. M. Gardiner, J. E. March, P. A. Kemp, and T. Bennett

Centre for Integrated Systems Biology and Medicine, School of Biomedical Sciences, Medical School, Queen's Medical Centre, Nottingham, United Kingdom

Submitted 8 August 2004 ; accepted in final form 24 December 2004

A possible involvement of endocannabinoids in a chronic model of endotoxemia was assessed by measuring the regional (renal, mesenteric, hindquarters) hemodynamic responses to continuous 24-h LPS infusion (150 µg·kg–1·h–1) in conscious, male Sprague-Dawley rats, in the absence or presence of the cannabinoid (CB1) receptor antagonist AM-251 (3 mg/kg). AM-251 inhibited the tachycardic and hindquarters vasodilator effects of LPS, but did not influence the other hemodynamic changes. In subsequent experiments, it was shown that the tachycardic and hindquarters vasodilator effects of LPS were also inhibited by the nonselective {beta}-adrenoceptor antagonist propranolol. In addition, the late (at 24 h) hindquarters vasodilator effects of LPS were inhibited by the {beta}2-adrenoceptor antagonist ICI-118551. Against the background of our previous work showing {beta}-adrenoceptor involvement in the cardiovascular effects of exogenous cannabinoids, we conclude that AM-251 may have been inhibiting endocannabinoid-modulated, sympathoadrenal-mediated activation of vasodilator {beta}-adrenoceptors in LPS-infused rats rather than suppressing a direct vasodilator action of endocannabinoids.

AM-251; endotoxemia; vasodilatation



Address for reprint requests and other correspondence: S. M. Gardiner, Centre for Integrated Systems Biology and Medicine, School of Biomedical Sciences, Univ. of Nottingham, Nottingham NG7 2UH, UK (E-mail: sheila.gardiner{at}nottingham.ac.uk)




This article has been cited by other articles:


Home page
J. Physiol.Home page
N. Alamdari, D. Constantin-Teodosiu, A. J. Murton, S. M. Gardiner, T. Bennett, R. Layfield, and P. L. Greenhaff
Temporal changes in the involvement of pyruvate dehydrogenase complex in muscle lactate accumulation during lipopolysaccharide infusion in rats
J. Physiol., March 15, 2008; 586(6): 1767 - 1775.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.